Results 31 to 40 of about 7,817 (197)
Faktor Risiko Non-genetik Inhibitor Faktor VIII pada Pasien Hemofilia A
Sari Pediatri, 2016 Latar belakang. Terbentuknya inhibitor atau antibodi terhadap FVIII pada pasien hemofilia A menyebabkan FVIII eksogen yang diberikan tidak dapat berfungsi. Penyebab bersifat multifaktorial terdiri atas faktor genetik dan lingkungan.
Ahmad Saifudin +2 more
doaj +1 more source
Hemofilia adquirida asociada a la infección por SARS-CoV2
Galicia Clínica, 2022 SARS-CoV2 infection has been found to be associated with coagulopathy. Although thrombotic complications have been more frequently reported, hematologic autoimmune disorders have also been described.
Catarina Medeiros +3 more
doaj +1 more source
Human Mutation, Volume 41, Issue 12, Page 2058-2072, December 2020., 2020 Abstract In hemophilia A and B, analysis of the F8 and F9 gene variants enables carrier and prenatal diagnosis and prediction of risk for the development of inhibitors. The PedNet Registry collects clinical, genetic, and phenotypic data prospectively on more than 2000 children with hemophilia.
Nadine G. Andersson +10 more
wiley +1 more source
Atención dental en pacientes diagnosticados con hemofilia grave a con presencia de inhibidores
Revista Científica Especialidades Odontológicas UG, 2020 Enfermedad genética recesiva, cuyo gen está asociado con el cromosoma sexual X, caracterizada por la deficiencia de algunos factores de coagulación. La hemofilia A se clasifica como deficiencia de factor FVIII, hemofilia B (FIX), hemofilia C (FXI), que ...
Andrea Caiza Rennella +3 more
doaj +1 more source
Hemofilia A adquirida: un diagnóstico de infarto
Revista Colombiana de Cardiología, 2022 La hemofilia A adquirida es una entidad poco reportada y potencialmente fatal, que se asocia con la aparición de autoanticuerpos contra el factor VIII de la coagulación. Si bien puede estar subestimada, se calcula una incidencia aproximada de 1 a 1.5 casos por millón de habitantes con una mortalidad reportada entre el 9 y el 33%.
Sandra B. Amado-Garzón +1 more
openaire +2 more sources
Haemophilia, Volume 26, Issue 6, Page 1019-1030, November 2020., 2020 Abstract Introduction The Haem‐A‐QoL is frequently utilized in haemophilia clinical trials and captures relevant aspects of disease impact. Thresholds for some domains ‘Physical Health’ (PH), ‘Sports & Leisure’ (S&L) and ‘Total Score’ (TS) have previously been identified to benchmark the amount of change that is meaningful to patients, but not been ...
Sylvia von Mackensen +5 more
wiley +1 more source
Molecular characterization of hemophilia B patients in Colombia
Molecular Genetics &Genomic Medicine, Volume 8, Issue 5, May 2020., 2020 This is the first molecular characterization of patients with Hemophilia B in Colombia. Using Sanger sequencing we found the patogenic variant in all patients. One large deletion of exon 3 and 4 hasn't been reported previously in international databases.
Yolima A. Parrado Jara +3 more
wiley +1 more source
Perdarahan Intrakranial pada Hemofilia: Karakteristik, Tata Laksana, dan Luaran
Sari Pediatri, 2016 Latar belakang. Perdarahan intrakranial merupakan salah satu penyebab mortalitas tertinggi pada hemofilia dan morbiditas berupa gangguan neurologis.
Novie Amelia C +3 more
doaj +1 more source
Haemophilia, Volume 26, Issue 3, Page 467-477, May 2020., 2020 Abstract Introduction Prophylaxis with factor VIII (FVIII) concentrates in children with haemophilia A (HA) is current standard of care. The benefit of prophylactic treatment for adult HA patients is not commonly accepted. Aim To investigate the benefit of prophylaxis over on‐demand treatment in adult and elderly patients with severe or non‐severe HA ...
Wolfgang Miesbach +7 more
wiley +1 more source
Revista Dor, 2016 RESUMO JUSTIFICATIVA E OBJETIVOS: A hemofilia é uma coagulopatia congênita, rara e crônica, caracterizada pelos surtos recidivantes de hemartroses.
Matheus Santos Gomes Jorge +3 more
doaj +2 more sources